Ignite Creation Date:
2024-05-05 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 9:54 AM
Study NCT ID:
NCT00747825
Status:
TERMINATED
Last Update Posted:
2011-10-12
First Post:
2008-09-04
Brief Title:
Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma
Sponsor:
Molecular Insight Pharmaceuticals Inc
Organization:
Molecular Insight Pharmaceuticals Inc
Organization Data
Organization:
Molecular Insight Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
SZ-M101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Molecular Insight Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None